Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the following changes to its management structure effective April 1, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback